The Hamner Institutes for Health Sciences and private equity firm PBM Capital Group (PBM) have thrashed out a venture for toxicity testing which they say could save the drug discovery industry billions.
Medgenics' Biopump could be the solution to the issues surrounding
protein therapy and is set to take on the $51bn US
biopharmaceutical market after raising £3.28m ($6.76m) in funding
in its Initial Public Offering.
Researchers have developed a biochip that could prove crucial in
future drug development. The technology measures electrical
activities of cells and can obtain 60 times more data in one
reading than is possible with current technology.
Researchers have isolated a protein that appears to encourage cell
movement when tumours begin to spread to other parts of the body
opening up the way for a drug that could block the beginning of
this dangerous process, or stop it...
A new ethics report has raised concerns about using animal-human
embryonic hybrids in drug testing in which the creation of these
chimeras are creating exciting avenues of research as well as
Centocor has enlisted Cardinal Health to use its rapid cell line
development technology to engineer cell lines expressing Centocor's
monoclonal antibodies, and speed up the development of new
Chromos has announced an expansion to an existing Pfizer
collaboration, which builds on research focusing on genetic
engineering of production cell lines with multiple genes to improve
bioreactor performance and reduce monoclonal...
Researchers have identified two proteins involved in the process
that controls plant growth, which may help explain why human cells
reject chemotherapy drugs and could form a basis for new oncology
Researchers have combined nanotechnology with biochemistry to
create synthetic membranes that, for the first time, enable direct
control of signalling activity in living T cells from the immune
system, which could lead to better development...
The drug resistance encountered by scientists when treating cancer
cells has been the subject of research by German scientists who
believe they have identified a cellular protein, which mediates a
Canada's Chromos Molecular Systems and AppTec Laboratory Services
have teamed up to provide the biopharmaceutical industry with a
broader range of cell line engineering and contract manufacturing
Vitra Bioscience has introduced a new nuclear translocation
application, a new method enabling the measurement of
cytoplasm-to-nucleus translocation, a critical indicator of
cellular response to various drug treatments.
Dharmacon has launched a range of small interfering RNA (siRNA)
transfection reagents designed specifically to enhance transfection
efficiency, a crucial procedure in initial drug target
identification to late-stage therapeutic development.
In-Pharmatechnologist.com recently reported on the opening of a new
biomanufacturing facility and laboratory by France's Lemnagene, a
new company specialising in the production of recombinant proteins
in duckweed. But why is...
The first commercial products from chloroplast transformation
technology (CTT) looks a distinct possibility after Chlorogen
signed a joint development and supply agreement with Sigma-Aldrich
to produce four specific proteins in tobacco...
A new method to improve the accuracy and speed of protein
visualization has been developed. The technique, which uses a novel
set of biosensor dyes, promises to dramatically increase the
accuracy and speed of the technique, used in...
Canada's Chromos Molecular Systems has entered into a collaborative
agreement with Centocor, a wholly-owned subsidiary of Johnson &
Johnson, to develop cell lines for the manufacture of biological
Contract research manufacturer Diosynth has forged a joint venture
with a Swiss firm for a technology that could dramatically reduce
the time and cost of developing new cell lines for manufacturing
proteins, writes Phil Taylor.